» Articles » PMID: 11511981

Hsal 1 is Related to Kidney and Gonad Development and is Expressed in Wilms Tumor

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2001 Aug 21
PMID 11511981
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Townes-Brocks syndrome (TBS) is a human genetic disorder with features including urogenital, limb, anal and cardiac malformations associated with mutations of the TBS gene, Hsal 1. To begin to understand the role of the Hsal 1 protein (p140) in both normal development and disease pathogenesis, both message and protein expression were evaluated in specific tissues associated with TBS. DNA sequence information for Hsal 1 predicts that this homeotic, Drosophila homologue (Sal) encodes a zinc-finger protein consistent with a transcription factor. mRNA for Hsal 1 was highly expressed in fetal kidney and brain, with detectable production in thymus and heart. p140 was found in fetal ureteric bud, fetal and postnatal renal tubular epithelium, and renal blastema. In the 14-week fetal testis, the Hsal 1 protein was specifically expressed in the testosterone producing Leydig cells while in adult gonads Hsal 1 was also found in both Leydig and Sertoli cells, spermatogonia of the testis, and granulosa cells of the ovary. Evaluation of Wilms tumor revealed consistently high expression of the gene product in the epithelial and blastemal components. These spatial and temporal patterns of expression for Hsal 1, and the phenotypic effects associated with TBS, suggest that Hsal 1 plays an important role in the development and functional maintenance of the kidney and gonads. Furthermore, the Hsal 1 gene product may play a part in the pathogenesis of specific neoplasms occurring in these organs in addition to its specific role in Townes-Brocks syndrome.

Citing Articles

SALL Proteins; Common and Antagonistic Roles in Cancer.

Alvarez C, Quiroz A, Benitez-Riquelme D, Riffo E, Castro A, Pincheira R Cancers (Basel). 2021; 13(24).

PMID: 34944911 PMC: 8699250. DOI: 10.3390/cancers13246292.


Epigenetic modification of as a novel biomarker for the prognosis of early stage head and neck cancer.

Misawa K, Misawa Y, Imai A, Mochizuki D, Endo S, Mima M J Cancer. 2018; 9(6):941-949.

PMID: 29581773 PMC: 5868161. DOI: 10.7150/jca.23527.


expression in acute myeloid leukemia.

Salman H, Shuai X, Nguyen-Lefebvre A, Giri B, Ren M, Rauchman M Oncotarget. 2018; 9(7):7442-7452.

PMID: 29484122 PMC: 5800914. DOI: 10.18632/oncotarget.23448.


Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress.

Farkas C, Martins C, Escobar D, Hepp M, Castro A, Evan G PLoS One. 2013; 8(9):e73817.

PMID: 24040083 PMC: 3765348. DOI: 10.1371/journal.pone.0073817.


The role of stem cell factor SALL4 in leukemogenesis.

Gao C, Kong N, Chai L Crit Rev Oncog. 2011; 16(1-2):117-27.

PMID: 22150312 PMC: 3238789. DOI: 10.1615/critrevoncog.v16.i1-2.110.